Are there any members who previously received treatment (R chop R DHAP) that included a BTK inhibitor...
Response to Your Hyper-Specific Trial Question
I appreciate you asking this directly—this is exactly the kind of question that requires human expertise rather than AI interpretation.
What I Can Tell You
Based on the NCCN Guidelines for Marginal Zone Lymphomas in my knowledge base, I can confirm that:
- R-CHOP and R-DHAP are recognized chemotherapy combinations used in lymphoma treatment
- BTK inhibitors like acalabrutinib are targeted therapies that work against specific proteins in lymphoma cells
- Treatment failure and progression do occur, and patients may be candidates for clinical trials after standard treatments don't work
However, your question asks about:
- Specific patient experiences (members who had this exact treatment sequence)
- A particular clinical trial (NIH ViPOR trial)
- Trial eligibility patterns for this specific scenario
Why I Can't Answer This Directly
**This is beyond educational interpretation of [ID removed] You're asking about:
- Real patient outcomes from a specific trial
- Trial enrollment criteria and actual acceptance patterns
- Peer experiences that would require access to trial databases or patient registries
What I Recommend Instead
For this question, contact:
-
NIH ViPOR Trial directly - They can tell you:
- Eligibility criteria for patients with prior BTK inhibitor failure
- Whether they have enrolled patients with your specific treatment history
- Contact: Search "NIH ViPOR lymphoma trial" or ask your oncologist for the trial contact information
-
Your lymphoma support group moderators - They may have members who fit this profile and can share experiences directly
-
Your oncologist or clinical trial navigator - They can:
- Review your specific treatment history
- Determine if you meet ViPOR eligibility
- Help with trial enrollment if appropriate
-
Lymphoma Research Foundation (lymphoma.org) - They maintain trial databases and can help match patients to appropriate studies
Why This Matters
Trial eligibility is highly individualized based on your complete medical history, current disease status, and specific trial protocols. Even if someone had a similar treatment sequence, their eligibility might differ from yours based on factors like:
- Timing since last treatment
- Current disease burden
- Performance status
- Other medical conditions
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Flag for human review: This question requires access to trial-specific data and real patient outcomes that are outside my educational scope. A clinical trial coordinator or your oncology team is the appropriate resource.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 2, 2026. Informational only — not a substitute for your oncology team.
Question asked:
Are there any members who previously received treatment (R chop R DHAP) that included a BTK inhibitor (acalabrutinib), had the treatment fail shortly afterward, and were then accepted into the NIH ViPOR trial?
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- This is the second time my heart is irregular and have tachycardia. I’ve completed 4 treatments r- chop. Anyone else...
- Desperately seeking help and experiences for relapsed-refractory double-hit DLBCL after CAR-T. A family member has...
- On my 5th round on r chop my LDH numbers are high climbing... Dr. Google is scaring me. Is it normal or not a good sign
- What should caregivers know about Lymphoma treatment
- Has anyone been through Glofitamab treatment
- What are first-line treatments for follicular lymphoma
- What can I do if my insurance denies my lymphoma treatment
- What happens if I choose no treatment for Lymphoma